(RTTNews) - BriaCell Therapeutics Corp. (BCTX), a clinical-stage biotechnology company, on Monday announced the resolution of lung metastasis in the first patient treated with Bria-OTS, a ...

Molecular profiling and genetic testing have revolutionised lung cancer treatment, says a doctor. They have enabled targeted ...

The discovery of these shared genetic drivers—applicable to cancers from the lungs ... and he emphasizes the potential impact. "It is remarkable to uncover common principles of metastasis ...

Also known as ocular metastasis, the condition has a serious ... “It seems that these cases represent a distinct subset of ...

Then, they tested microrobots on mice with lung-metastasized melanoma by administering four 75 microgram DOX doses over a week. Bioluminescence results indicated that algae-NP(DOX) microrobots ...

2). From the lymph nodes, however, there are no direct lymphatic routes to the sites where breast cancer metastases are often found — bone, liver, brain and lungs — so cells in the lymphatic ...

These specialized macrophages, he notes, appear early in embryonic ... the number of activated DCCs and subsequent metastases ...

Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS™ ...

Therapeutics announces an unprecedented clinical response including resolution of a lung metastasis with stable disease ...